Randomized controlled study of the T-type calcium channel antagonist MK-8998 for the treatment of acute psychosis in patients with schizophrenia.
Hum Psychopharmacol. 2013 Mar;28(2):124-33. doi: 10.1002/hup.2289.
Hum Psychopharmacol. 2013.
PMID: 23532746
Clinical Trial.